自1986年以来，Athens Research & Technology Inc.一直致力于人类蛋白质的纯化及相应多克隆抗血清的开发。我们专注于提供高纯度、高活性的人类蛋白质产品，常规纯化项目包括丝氨酸蛋白酶、蛋白酶抑制剂、中性粒细胞酶、载脂蛋白、脂蛋白、血小板蛋白、转铁蛋白、免疫球蛋白等。二十五年来，全球科研人员持续采购我们的研究试剂，这些产品在炎症、冠心病、自身免疫疾病、癌症、阿尔茨海默病等重大科学研究的文献中屡被引用。
我们还能从动物血清和组织中分离蛋白质。
国际诊断与制药行业将我们的产品作为体外诊断试剂、免疫检测试剂盒的核心组分，同时应用于细胞培养基（包括干细胞培养基）。雅典研究与技术公司的蛋白质也被生物治疗药物研发人员用于概念验证实验。
我们提供品质可靠的产品与客户服务——我们只销售自主研发纯化的产品。期待与您建立合作关系。
若您需要定制化研究服务，将能提供项目所需的特殊试剂。
货号:16-16-012901
分子量（MW）：70,000
消光系数：0.703
通过20 mM双亚氨基三（羟甲基）甲烷（Bis-Tris）缓冲液（pH 6.4，含200 mM NaCl）冻干制得。
储存条件：≤ -20°C
人血浆α2抗纤溶蛋白（凝血因子）
可有效抑制纤溶酶原激活剂诱导的纤维蛋白凝块溶解。血浆中浓度约为70微克/毫升。α-抗纤溶蛋白缺乏症是一种罕见的凝血功能障碍，会导致纤溶活性不受限。此类患者可在术前接受治疗性α2抗纤溶蛋白（A2AP），以预防术后出血。
纯度：≥95%（通过SDS-聚丙烯酰胺凝胶电泳检测）
活性：≥5.0 单位/毫克
本品由经FDA批准检测显示HBsAg、抗HCV、抗HBc阴性，且抗HIV 1/2阴性的血浆制备。
Athens Research & Technology产品为实验室试剂，不可用于人体或作为药物用途，仅限研究使用。
产品引用文献：
Zimmerman, Thomas P., Valery Novokhatny, Shan Jiang, and James D. Colandene. "Reversibly inactivated acidified plasmin composition." U.S. Patent Application 13/761,684, filed February 7, 2013.
Singh S, Houng A, Reed GL.
Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli.
Circulation. 2017 Mar 14;135(11):1011-1020. doi: 0.1161/CIRCULATIONAHA.116.024421. Epub 2016 Dec 27
货号:K060-H1
人髓过氧化物酶（MPO）酶联免疫吸附试验（EIA）试剂盒 特点：
用途——检测多种基质中的人MPO
样本类型——血清、无血小板肝素血浆、唾液、尿液或组织培养液
样本量/盒——40份（重复检测）
灵敏度——0.068纳克/毫升
稳定性——液体试剂于4°C下稳定保存
快速出结果——2.5小时内完成
髓过氧化物酶（MPO）是一种四聚体含血红素蛋白，主要由中性粒细胞大量产生，在其中发挥重要的抗微生物作用。当粒细胞脱颗粒时，MPO会被释放到细胞外空间。作为中性粒细胞“呼吸爆发"的一部分，它能通过过氧化氢（H₂O₂）和氯离子（Cl⁻）生成次氯酸（HOCl）。此外，MPO还能利用过氧化氢氧化酪氨酸生成酪氨酰自由基。次氯酸和酪氨酰自由基均具有细胞毒性，可有效杀灭细菌及其他病原体。遗传性髓过氧化物酶缺乏症会增加个体患免疫缺陷的风险。
研究表明，MPO水平升高与冠状动脉疾病相关。2003年有研究提出，MPO可能作为胸痛患者心肌梗死的敏感预测指标。此后，大量文献（已发表逾百篇）进一步证实了MPO检测在心脏病患者中的临床价值。2010年的补充研究进一步优化了这一临床应用：通过联合检测MPO和C反应蛋白（CRP），相较于单独检测CRP，可更精准地预测死亡风险。
参考文献：
Zhang et al. (2001) Association between myeloperoxidase levels and risk of coronary artery disease; JAMA, 286 2135
Brennan et al. (2003) Prognostic value of myeloperoxidase in patients with chest pain; New Engl. J. Med., 349 1595
Heslop et al. (2010) Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography; J. Am. Coll. Of Cardiol. 55 1102
Athens研究与技术公司（ART）与Arbor检测公司合作，推出了目前MPO EIA试剂盒。Arbor检测公司的创始团队及顶尖科学家自1982年起便致力于研发高质量检测试剂盒。ART依托其30年在蛋白质纯化技术领域的经验，成功分离出高纯度抗原；Arbor检测团队在此基础上，通过抗体配对设计、精细优化及严格的质量控制（其标志性优势），最终开发出这款顶级酶联免疫吸附试验试剂盒。经验证，Athens研究与技术/Arbor检测人MPO EIA试剂盒适用于血清、无血小板肝素血浆、唾液、尿液及组织培养液样本，2.5小时内即可完成检测，灵敏度达0.068纳克/毫升（注：原文此处可能存在笔误，前文灵敏度为0.068 ng/mL，末段误写为0.68 ng/ml，翻译保留原文数据）。该试剂盒可通过任一合作公司购买（Arbor检测货号：K060-H1；Athens研究与技术货号：K060-H1）。
分子量（MW）：28,000
消光系数（Extinction Coefficient）：1.22
冷冻保存于10 mM NH₄HCO₃缓冲液（pH 7.4）中
储存条件：≤-70°C
购买纯化天然人载脂蛋白AI（ApoA1）（来源于人血浆）。可提供批量采购。
高密度脂蛋白（HDL）中75%的载脂蛋白A为Apo AI。Apo AI水平与冠心病风险呈负相关。此外，Apo AI被认为可激活卵磷脂胆固醇酰基转移酶（LCAT）。正常血浆中，Apo AI水平范围为90-130 mg/100 mL。
纯度：通过SDS-PAGE检测≥95%
本产品由经FDA批准方法检测为阴性的血浆制备（乙肝表面抗原[HBsAg]、丙肝抗体[anti-HCV]、乙肝核心抗体[anti-HBc]无反应；人类免疫缺陷病毒1型/2型抗体[anti-HIV 1 & 2]阴性）。
Athens Research & Technology产品为实验室试剂，不可用于人体或任何药物用途，仅限研究使用。
产品引用文献： Soffientini, Ugo, et al. "Intracellular cholesterol transporters and modulation of hepatic lipid metabolism: Implications for diabetic dyslipidaemia and steatosis." Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 1841.10 (2014): 1372-1382.
Soffientini U, Dolan S, Graham A.
Cytosolic lipid trafficking proteins STARD4 and STARD5 modulate hepatic neutral lipid metabolism: implications for diabetic dyslipidaemia and steatosis.
Journal of Diabetes and Metabolism, Volume 6, Issue number 588. DOI: 10.4172/2155-6156.1000558.
Winford, Sidney, Moriah Tobin, and Eitan Gross. "Surface-induced assembly of apolipoprotein AI: Implications for symmetry-driven non-cooperative clustering."Journal of Crystal Growth 343, no. 1 (2012): 38-44.
Konno, Shunichi, Masami Tanio, Itsuko Ishii, Kazuhiko Machida, Fumiaki Matsumoto, Kaneshige Satoh, Masayuki Aso, and Yasushi Saito. "Ceiling culture-derived proliferative adipocytes are a possible delivery vehicle for enzyme replacement therapy in lecithin: cholesterol acyltransferase deficiency." Open Gene Therapy Journal 4 (2011): 1-10.
Scharadin TM, et al.
Synthesis and biochemical characterization of EGF receptor in a water-soluble membrane model system.
PLOS One, 2017 Jun 6;12(6).
Prathipati P, Zhu J, Dong X.
Development of novel HDL-mimicking α-tocopherol-coated nanoparticles to encapsulate nerve growth factor and evaluation of biodistribution.
Eur J Pharm Biopharm. 2016 Nov;108:126-135. doi: 10.1016/j.ejpb.2016.08.005. Epub 2016 Aug 12.
技术深度与广度兼备：覆盖抗体开发（多克隆/单克隆/重组抗体）、功能试剂盒（ELISA/Western Blot/流式检测）、细胞培养（原代细胞/干细胞/类器官培养基）三大核心技术方向，可满足从基础研究到转化医学的全流程需求。
严格的品控体系：所有产品均经过“原料溯源-工艺验证-性能测试-批次留样"四步质控，关键指标（如抗体亲和力、试剂盒灵敏度）的批次间差异率≤5%，确保实验结果可重复。
定制化服务响应快：针对客户的个性化需求（如新型抗原抗体开发、特殊物种细胞培养基优化），提供“需求沟通-方案设计-样品测试-量产交付"的全周期支持，平均定制周期较行业缩短30%。
全球化的服务网络：在美国、欧洲及亚太地区设立仓储中心，支持48小时内紧急订单发货；配备专业的技术支持团队（含中文服务），为全球客户提供7×12小时技术咨询。
高校/科研院所实验室：为基础医学、生物学、药学等领域的师生提供高性价比的研究工具，支持论文发表与课题申报。
生物医药企业研发部：为新药靶点验证、药效评价、临床前研究提供定制化试剂（如疾病模型动物用抗体、细胞功能检测试剂盒）。
诊断试剂开发商：提供高特异性抗原/抗体原料，用于传染病、肿瘤标志物等体外诊断试剂盒的开发。
类器官/器官芯片研究团队：定制化培养基与基质胶产品，支持干细胞衍生类器官的高效培养与功能维持。
Q1：AR的抗体在跨物种检测中表现如何？
A：AR抗体开发时均经过多物种同源性分析，优先选择保守表位设计抗原，确保在人、小鼠、大鼠等常见物种中具有良好的交叉反应性。若需特殊物种（如兔、猴）检测，可提供定制化抗原表位设计服务。
Q2：定制化产品的交付周期需要多久？
A：常规定制（如抗体亚型转换）约4-6周；复杂项目（如全新抗原开发+抗体筛选）约12-16周，具体时间根据需求复杂度评估后会与客户确认。
Q3：产品出现质量问题如何解决？
A：AR提供“30天无理由退换"服务（需保留完整包装与使用记录）。若因产品质量问题导致实验失败，经技术验证后可免费补发或退款，并安排专人跟进解决。
Q4：是否支持小批量采购？
A：是的，AR提供毫克级抗体、微升级试剂盒及小规格培养基的采购选项，起订量可根据客户需求协商调整，降低中小实验室的采购成本。
货号 | 品名 | 规格 | 品牌 |
16-16-090707-1M | Immunoglobulin G1, Human Myeloma Plasma | 1mg | Athens Research |
16-14-051200-100ug | Elastase, Human Neutrophil | 100ug | Athens Research |
16-16-090707-2M-1MG | Immunoglobulin G2 Human Myeloma Plasma | 1mg | Athens Research |
12-16-121601-1mg | Lipoprotein (a), Human Plasma | 1mg | Athens Research |
16-16-032001-LEL-1gram | Transferrin (HOLO), Human Plasma, Tissue Culture Grade | 1gram | Athens Research |
16-16-090705-100ug | Immunoglobulin E, Human Plasma | 100ug | Athens Research |
12-16-121601-100ug | Lipoprotein (a), Human Plasma | 100ug | Athens Research |
16-14-130000-1mg | Myeloperoxidase, Human Neutrophil | 1mg | Athens Research |
16-16-090701-1M-10mg | Immunoglobulin A1, Human Myeloma Plasma | 10mg | Athens Research |
16-16-161200-1mg | Plasminogen, Human Plasma | 1mg | Athens Research |
16-16-011609-5mg | Alpha 1 Antitrypsin, Human Plasma | 5mg | Athens Research |
16-16-120303-1mg | Apolipoprotein CIII, Human Plasma | 1mg | Athens Research |
16-16-161213-L-1mg | Plasmin, Human Plasma (lyophilized) | 1mg | Athens Research |
16-16-090701-1M-1mg | Immunoglobulin A1, Human Myeloma Plasma | 1mg | Athens Research |
16-16-090701-1M-5mg | Immunoglobulin A1, Human Myeloma Plasma | 5mg | Athens Research |
16-16-090707-1M-10mg | Immunoglobulin G1, Human Myeloma Plasma | 10mg | Athens Research |
12-16-120412-OX-1mg | Lipoproteins, Oxidized, Low Density, Human Plasma | 1mg | Athens Research |
16-14-012621-1mg | Azurocidin, Human Neutrophil | 1mg | Athens Research |
16-14-130000作废 | Myeloperoxidase, Human Neutrophil | 100ug | Athens Research |
16-16-090713-10mg | Immunoglobulin M, Human Plasma | 10mg | Athens Research |
16-16-090713-M-1MG | Immunoglobulin M (IgM) Human Myeloma Plasma | 1mg | Athens Research |
16-16-090713-Mfc5u-1mg | Immunoglobulin M, Fc5mu, Human Plasma | 1mg | Athens Research |
16-20-201319 | Thrombospondin, Human Platelet | 25ug | Athens Research |
16-05-030112-P-1mg | Calpain-1, Porcine Erythrocytes | 1 mg | Athens Research |
16-14-030107-100ug | Cathepsin G, Human Neutrophil | 100ug | Athens Research |
16-14-051200-1mg | Elastase, Human Neutrophil | 1mg | Athens Research |
16-14-130000-100ug | Myeloperoxidase, Human Neutrophil | 100ug | Athens Research |
16-14-161820-25ug | Proteinase 3 (PR3), Human Neutrophil | 25ug | Athens Research |
16-16-030402-100ug | C4b-Binding Protein, Human Plasma | 100ug | Athens Research |
16-16-030402-1mg | C4b-Binding Protein, Human Plasma | 1mg | Athens Research |
16-16-081907-1mg | Alpha 2 HS Glycoprotein, Human Plasma | 1mg | Athens Research |
16-16-090701-10mg | Immunoglobulin A1 (IgA1), Human Myeloma Plasma | 10mg | Athens Research |
16-16-090701-2M-1mg | Immunoglobulin A2, Human Plasma | 1mg | Athens Research |
16-16-090707-1-1mg | Immunoglobulin G1, Human Normal Plasma | 1mg | Athens Research |
12-16-030825-1mg | Chylomicrons, Human Plasma | 1mg | Athens Research |
16-05-030112-P-100ug | Calpain-1, Porcine Erythrocytes | 100 ug | Athens Research |
16-12-030102-25ug | Cathepsin B, Human Liver | 25ug | Athens Research |
16-12-030102-50ug | Cathepsin B, Human Liver | 50ug | Athens Research |
16-13-090701-10mg | Secretory IgA, Human Colostrum | 10mg | Athens Research |
16-13-090701-5mg | Secretory IgA, Human Colostrum | 5mg | Athens Research |
16-14-012621-100ug | Azurocidin, Human Neutrophil | 100ug | Athens Research |
16-14-161820-100ug | Proteinase 3, Human Neutrophil | 100ug | Athens Research |
16-16-010700-10mg | Alpha 1 Acid Glycoprotein (A1AGP), Human Plasma | 10mg | Athens Research |
16-16-011609-1mg | Alpha 1 Antitrypsin, Human Plasma | 1mg | Athens Research |
16-16-012020-1mg | Antithrombin III, Human Plasma | 1mg | Athens Research |
16-16-012901-100UG | Alpha 2 Antiplasmin, Human Plasma | 100ug | Athens Research |
16-16-032001-1gram | Transferrin (HOLO), Human Plasma | 1 gram | Athens Research |
16-16-032001-CM-1mg | Transferrin, Cynomolgus Monkey ** | 1mg | Athens Research |
16-16-032001-CM-5mg | Transferrin, Cynomolgus Monkey | 5 mg | Athens Research |
16-16-080116-1/1-1mg | Haptoglobin, Phenotype 1-1, Human Plasma | 1mg | Athens Research |
16-16-080116-2/2-1mg | Haptoglobin, Phenotype 2-2, Human Plasma | 1mg | Athens Research |
16-16-080116-5mg | Haptoglobin, Human Plasma, Mixed Type | 5mg | Athens Research |
16-16-090109-100ug | Inter Alpha Inhibitor Proteins (IaIp), Human Plasma | 100ug | Athens Research |
16-16-090707-1M-5mg | Immunoglobulin G1, Human Myeloma Plasma | 5mg | Athens Research |
16-16-090707-FC-1mg | Immunoglobulin G, FC Fragment, Human Plasma | 1mg | Athens Research |
16-16-090713-1mg | Immunoglobulin M, Human Plasma | 1mg | Athens Research |
16-16-110112-RAT-50ug | Kallikrein, Rat Plasma | 50ug | Athens Research |
16-16-120101-1mg | Apolipoprotein AI, Human Plasma | 1mg | Athens Research |
16-16-120500-1mg | Apolipoprotein E, Human Plasma | 1mg | Athens Research |
16-16-120500-50ug | Apolipoprotein E, Human Plasma | 50ug | Athens Research |
16-16-161801-1mg | Prealbumin, Human Plasma (Transthyretin) | 1mg | Athens Research |
01-05-030000-1ML | Anti-Catalase Polyclonal Ab, Human Erthrocyte | 1ml | Athens Research |
12-16-120412-5mg | Lipoproteins, Low Density, Human Plasma | 5mg | Athens Research |
12-16-221204-5mg | Lipoproteins, Very Low Density, Human Plasma | 5mg | Athens Research |
16-05-030000-1mg | Catalase, Human Erythrocyte (50 KU per mg) | 1mg | Athens Research |
16-12-030104-100ug | Cathepsin D, Human Liver | 100ug | Athens Research |
16-12-030104-25ug | Cathepsin D, Human Liver | 25ug | Athens Research |
16-12-030112-25ug | Cathepsin L, Human Liver | 25ug | Athens Research |
16-13-090701-1mg | Secretory IgA, Human Colostrum | 1mg | Athens Research |
16-13-A20103 | Apolactoferrin, Human Milk | 5mg | Athens Research |
16-14-030107-50ug | Cathepsin G, Human Neutrophil | 50ug | Athens Research |
16-15-160518-100ug | Eosinophil Peroxidase, Human Eosinophils | 100ug | Athens Research |
16-16-011202-CM-10mg | Albumin, Cynomolgus Monkey ** | 10mg | Athens Research |
16-16-012013-1mg | Alpha 2 Macroglobulin, Human Plasma | 1mg | Athens Research |
16-16-012400-1mg | Alpha 1 Antichymotrypsin, Human Plasma | 1mg | Athens Research |
16-16-012901-1MG | Alpha 2 Antiplasmin, Human Plasma | 1mg | Athens Research |
16-16-012901-500UG | Alpha 2 Antiplasmin, Human Plasma | 500ug | Athens Research |
16-16-030518-1mg | Ceruloplasmin, Human Plasma | 1mg | Athens Research |
16-16-080116-1mg | Haptoglobin, Human Plasma, Mixed Type | 1mg | Athens Research |
16-16-080513-LEL | Hemopexin, Low Endotoxin Level, Human Plasma | 1mg | Athens Research |
16-16-090109-1mg | Inter Alpha Inhibitor Proteins (IaIp), Human Plasma | 1mg | Athens Research |
16-16-090109-25ug | Inter Alpha Inhibitor Proteins (IaIp), Human Plasma | 25ug | Athens Research |
16-16-090701-1mg | Immunoglobulin A, Human Plasma | 1mg | Athens Research |
16-16-090705 | Immunoglobulin E, Human Plasma 1mg | 1mg | Athens Research |
16-16-090705-M-Lambda-100ug | Immunoglobulin E, Human Myeloma Plasma, Lambda | 100ug | Athens Research |
16-16-090707 | 人免疫球蛋白 | 毫克 | Athens Research |
16-16-090707-2M-10mg | Immunoglobulin G2, Human Myeloma Plasma | 10mg | Athens Research |
16-16-090707-2M-5mg | Immunoglobulin G2, Human Myeloma Plasma | 5mg | Athens Research |
16-16-090707-4M-1mg | Immunoglobulin G4, Human Myeloma Plasma | 1mg | Athens Research |
16-16-090707-Fc-10mg | Immunoglobulin G, Fc Fragment, Human Plasma | 10mg | Athens Research |
16-16-090713-BULK | Immunoglobulin M, Human Plasma | 1g | Athens Research |
16-16-110112-50ug | Kallikrein, Human Plasma (frozen) | 50ug | Athens Research |
16-16-110112-CM | Kallikrein, Cynomolgus Monkey Plasma | 50ug | Athens Research |
16-16-110914-L-1mg | Kininogen, Low Molecular Weight, Human Plasma | 1mg | Athens Research |
16-16-120101-500ug | Apolipoprotein AI, Human Plasma | 500ug | Athens Research |
16-16-120101-LEL-1mg | Apolipoprotein AI, Human Plasma, LEL | 1mg | Athens Research |
16-16-120200-500ug | Apolipoprotein B, Human Plasma | 500ug | Athens Research |
16-16-180603-250ul | Rheumatoid Factor (IgM), Human Plasma | 250ul | Athens Research |
16-16-A32001-100mg | APO Transferrin, Human Plasma | 100mg | Athens Research |
16-16-A32001-1gram | APO Transferrin, Human Plasma | 1gram | Athens Research |
